Image

Motor Imagery-Enhanced Rehabilitation Modulates Cortical Plasticity and Functional Recovery After ACL Reconstruction

Motor Imagery-Enhanced Rehabilitation Modulates Cortical Plasticity and Functional Recovery After ACL Reconstruction

Recruiting
18-45 years
All
Phase N/A

Powered by AI

Overview

Part 1: Neural Correlates of Motor Imagery in ACLR Patients This cross-sectional study aims to systematically compare differences in electroencephalographic (EEG) activity between patients who have returned to sport one year after anterior cruciate ligament reconstruction (ACLR) and healthy controls during functional tasks and associated motor imagery. We will collect EEG activity and behavioral performance data from both groups during task execution and imagination. The primary objective is to verify whether ACLR patients exhibit a specific deficit in motor imagery capability and to characterize the abnormal functional patterns within their central sensorimotor networks. By providing an objective, neurophysiological explanation for why patients struggle to return to sport, this study seeks to establish quantifiable baseline metrics for subsequent interventional research.

Part 2: Effects and Cortical Plasticity Changes Following Motor Imagery-Enhanced Rehabilitation This randomized controlled trial (RCT) combines short-term intervention with long-term follow-up to systematically evaluate the efficacy and mechanisms of motor imagery therapy in ACLR patients. The specific objectives are threefold: First, to verify the immediate effects of the intervention on enhancing neuroplasticity and restoring motor function. Second, to assess the long-term impact on definitive clinical outcomes-specifically return-to-sport rates and time to return-through a 12-month follow-up. Third, to perform a longitudinal analysis determining whether early improvements in neurophysiological indicators can predict subsequent gains in motor performance and successful return-to-sport outcomes.

Description

Part 1 employs a cross-sectional design, comparing patients one year after anterior cruciate ligament reconstruction (ACLR) (experimental group) with healthy adults (control group). This phase aims to acquire electroencephalography (EEG) and lower limb functional data across different states to elucidate the correlation between cortical function and motor behavior.

Part 2 will conduct a 12-week randomized controlled trial (RCT). ACL rupture patients will be allocated to either a motor imagery intervention group or a conventional rehabilitation control group. We will integrate EEG and kinematic analysis to systematically evaluate the therapy's effects on knee function, neuromuscular control, and brain network connectivity. Furthermore, by combining longitudinal EEG and resting-state functional magnetic resonance imaging (rs-fMRI), we will investigate the underlying neuroplastic mechanisms driving functional remodeling within the sensorimotor networks. This research is expected to establish a novel, active intervention strategy based on the "central-driven peripheral" paradigm for ACL postoperative rehabilitation.

Eligibility

Part 1: Participants

Study Design:

  • This study will recruit 20 patients at 12 months after ACL reconstruction and 20 healthy controls.
  • Age range: 18-45 years.

Inclusion Criteria for Patient Group:

  • Age: 18-45 years old.
  • Body Mass Index (BMI): ≥18.5 kg/m² and \<35 kg/m².
  • Injury Type: First-time unilateral isolated ACL rupture, reconstructed at our hospital.
  • Surgical Technique: Single-bundle hamstring tendon autograft transplantation.
  • Ligament Stability: No injury or only mild injury (Grade I) to the PCL, MCL, or LCL.
  • Postoperative Timeline: 12 months after ACL reconstruction.
  • Consent: Voluntary participation with signed informed consent.

Exclusion Criteria for Patient Group:

  • Delayed Surgery: ACL reconstruction performed \>6 months after injury.
  • Combined Injuries: Severe injury (\>Grade I) to PCL, MCL, or LCL; severe meniscus tear.
  • Previous Surgery: History of lower limb knee surgery (e.g., meniscus repair, arthroplasty).
  • Comorbidities: Existing knee diseases (e.g., osteoarthritis, tumors, rheumatoid arthritis, fracture).
  • Systemic/Cognitive Issues: Severe cardiac, pulmonary, cerebral disease, or hepatic/renal dysfunction; visual or cognitive impairment.
  • Imagery Ability: Score \<55 on the KVIQ-20.

Inclusion Criteria for Healthy Controls:

  • Age: 18-45 years old.
  • Body Mass Index (BMI): ≥18.5 kg/m² and \<35 kg/m².
  • Medical History: No history of surgery, injury, or chronic lower limb joint disease.
  • Neurological Status: No visual/cognitive impairment or neurological disorders.
  • Gait: No trauma or disease causing gait abnormalities.
  • Consent: Voluntary participation with signed informed consent.
  • Imagery Ability: Score \<55 on the KVIQ-20. Study 2: Participants

Study Design:

  • This study aims to recruit 40 patients meeting the specified criteria.
  • Randomization: Participants will be randomly allocated into an experimental group (N=20) and a control group (N=20).

Inclusion Criteria for Patients:

  • Age: 18-45 years old.
  • Body Mass Index (BMI): ≥18.5 kg/m² and \<35 kg/m².
  • Injury Type: First-time unilateral isolated ACL rupture, reconstructed at our hospital.
  • Surgical Technique: Single-bundle hamstring tendon autograft transplantation.
  • Ligament Stability: No injury or only mild injury (Grade I) to the PCL, MCL, or LCL.
  • Consent: Voluntary participation with signed informed consent.
  • Exclusion Criteria for Patients:
  • Delayed Surgery: ACL reconstruction performed \>6 months after injury.
  • Combined Injuries: Severe injury (\>Grade I) to PCL, MCL, or LCL (Grade II-III); severe meniscus tear.
  • Previous Surgery: History of lower limb knee surgery (e.g., meniscus repair, ligament reconstruction, arthroplasty).
  • Comorbidities: Existing knee diseases (e.g., osteoarthritis, tumors, rheumatoid arthritis, tuberculosis, infection).
  • Systemic/Cognitive Issues: Severe cardiac, pulmonary, cerebral disease, or hepatic/renal dysfunction; visual or cognitive impairment.
  • Imagery Ability: Score \<55 on the KVIQ-20.

Study details
    ACL Injury

NCT07833189

Peking University Third Hospital

20 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.